Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epionce vs Hydroquinone for Hyperpigmentation and Melasma
NCT02138539Phase 4Completed
- Sponsor
- Sadick Research Group
- Start
- Oct 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Epionce in melasma, Hyperpigmentation, sponsored by Sadick Research Group. Started Oct 2013; status: completed.
02
Drugs
Epionce
03
Conditions
melasmaHyperpigmentation
Beyond the preview
Go deeper on NCT02138539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02138539.